2010

1. Determination of HER2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: A European multicentre study involving 168 specimens

   Histopathology, Vol. 56, Núm. 4, pp. 472-480